Please assess the completion status of the following clinical trial:

Trial Title: Neuromodulation of Conscious Perception: Investigating Thalamic Roles Through Ultrasonic Stimulation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Must be right-handed.~* Must have normal or corrected-to-normal vision (while wearing contact lenses). Please note: persons who need eyeglasses to achieve 20/20 vision cannot be included in this study as eyeglasses cannot be worn during the study visit.~* Must not be on any medications for any neurological, psychological, or psychiatric conditions.~* Must be English speaking.~* Must be capable of giving written informed consent.~Exclusion Criteria:~• Vision that is not 20/20, or vision that is not corrected to 20/20 while wearing contact lenses.~Please note: persons needing eyeglasses to achieve 20/20 vision cannot be included in this study as eyeglasses cannot be worn during the study visit.~* History of significant head injury with loss of consciousness.~* Learning disability or other developmental disorder.~* Medication use for any neurological, psychological, or psychiatric conditions.~* Any impairment (sensory or motor loss), activity, or situation that in the judgment of the study coordinator or Principal Investigators would prevent satisfactory completion of the study protocol.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- LIFUP excitation (Type: EXPERIMENTAL): The study will involve the enrollment of 60 participants, who will be randomly assigned to two groups, with each group consisting of 30 participants. The participants will be divided based on the type of transcranial LIFUP they will receive, either excitation or inhibition, targeting four specific thalamic areas.
- LIFUP inhibition (Type: EXPERIMENTAL): The study will involve the enrollment of 60 participants, who will be randomly assigned to two groups, with each group consisting of 30 participants. The participants will be divided based on the type of transcranial LIFUP they will receive, either excitation or inhibition, targeting four specific thalamic areas.

Based on this trial design, predict the completion outcome and termination type (if applicable).